Abstract
In a study with both open and double-blind phases, a therapeutic response to sulpiride was first established in 18 chronic schizophrenic inpatients. Following this, two dosage regimens, a morning only dose, and the same daily total dose in two equal fractions at 8 a.m. and 4 p.m., were compared using a balanced design, crossover, placebo controlled study. Clinical effects were evaluated by means of the Brief Psychiatric Rating Scale (BPRS). There was a significant reduction in the mean BPRS score in all phases of the study. There was no significant difference between the mean BPRS scores resulting from the two dosage regimens. The study indicated that the two dosage regimens were equally efficacious.
Similar content being viewed by others
References
Bjerkenstedt L, Harnryd C, Sedvall G (1979) Effect of sulpiride on monaminergic mechanisms in psychotic women. Psychopharmacology 64:135–139
Borenstein P, Gekiere F (1981) Sulpiride, psychosis and mood. Advances Biological Psychiatry 7:138–153
Borenstein P, Cujo Ph, Champion C, Olivenstein C (1968) Étude d'un nouveau psychotrope: Le sulpiride (1403RD). 1. Méthode et resultats cliniques. Ann Med Psychol (Paris) 2L:90–99
Borenstein P, Champion C, Cujo Ph, Gekiere F, Olivenstein C, Kramara P (1969) Un psychotrope original: Le sulpiride. Sem Hosp Paris 45:1301–1314
Carrare J (1968) Etude de sulpiride sur Métat psychique de 40 malades mentaux. Ann Med Psychol (Paris) 2:560–574
Cassano GB, Castrogiovanni P, Conti L, Bonollo L (1975) Sulpiride versus haloperidol in schizophrenia: A double-blind comparative trial. Curr Ther Res 17:189–201
Collard J (1969) Le sulpiride, un neuroleptic singulier antiautistique et thymanaleptique. Sem Hop Paris 45:3028–3033
Elizur A, Davidson S (1975) The evaluation of the anti-autistic activity of sulpiride. Curr Ther Res 18:578–584
Jenner P, Marsden CD (1979) Mini-review. The substituted benazamides — a novel class of dopamine antagonists. Life Sci 25:479–486
Justin-Besancon L, Thiminet M, Laville C, Margarit J (1967) Constitution chimique et propriétés biologiques du sulpiride. C R Acad Sci (D) (Paris) 265:1253–1254
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Mancini AM, Guitelman A, Vargas CA, Debeljuk L, Aparicio NJ (1976) Effect of sulpiride on serum prolactin levels in humans. Clin Endocrinol Metab 42:181–184
Meltzer HY, So R, Miller RJ, Fang VS (1979) Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spoperidol in the rat pituitary and striatum, with in vivo effects on rat prolactin secretion. Life Sci 25:573–584
Mielke DH, Gallant DM, Kessler C (1977b) An evaluation of a unique new antipsychotic agent, sulpiride: Effect on serum prolactin and growth hormone levels. Am J Psychiatry 134:1371–1375
Mielke DH, Gallant DM, Roniger JJ, Kessler C, Kessler LR (1977a) Sulpiride: Evaluation of antipsychotic activity in schizophrenic patients. Dis Nerv Syst 38:569–571
Nishiura M (1976) Clinico-pharmacological studies of sulpiride. Curr Ther Res 20:164–172
Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812
Pichot P, Dreyfus JF (1977) A multicentre double-blind clinical comparison of chlorpromazine and sulpiride in acute psychoses. Abstract Sixth World Congress Psychiatr, Hawaii
Pinto CAC (1972) O uso do sulpiride em esquizofrenia (Ensaio duplp cego). Bol de Psiquiatr 5:103–142
Rama Rao VA, Bailey J, Bishop M, Coppen A (1981) A clinical and pharmacodynamic evaluation of sulpiride. Psychopharmacology 73:77–80
Sedvall G, Bjerkenstedt L, Lindstrom L, Wode-Heldgodt B (1978) Clinical assessment of dopamine receptor blockade. Life Sci 23:425–430
Seppala T (1976) Effect of chlorpromazine or sulpiride and alcohol on psychomotor skills related to driving. Arch Int Pharmacodyn Ther 223:311–323
Toru M, Shimazono Y, Miyasaka M, Kikubo T, Mori Y, Nasu T (1972) A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia. J Clin Pharmacol 12:221–229
Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G (1980) The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur J Clin Pharmacol 17:385–391
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lewis, D.M., Bond, H.R. & Curry, S.H. Sulpiride trial in chronic schizophrenia with comparison of two dosage regimens. Psychopharmacology 80, 259–262 (1983). https://doi.org/10.1007/BF00436165
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00436165